Literature DB >> 15256070

The comparison of different protocols for expansion of umbilical-cord blood hematopoietic stem cells.

Mihaela Chivu1, Carmen C Diaconu, Coralia Bleotu, Irina Alexiu, Lorelei Brasoveanu, C Cernescu.   

Abstract

Hematopoiesis is maintained by the activity of multipotent stem cells, which have the dual capacity to self-renew and to differentiate into all of the blood cell lineages. The major challenge of stem cells based regenerative therapy is to expand ex vivo the primitive compartment to increase transplantable stem cells number. The present study was designed to evaluate several culture systems for in vitro maintenance of umbilical cord blood stem cells. The influences of different growth conditions such as stromal feeder layer, cytokines supplement and placental conditioned medium (PCM) have been evaluated over a relatively short period of time on CD34(+) cell expansion and maintenance of clonogenic progenitors. When cells were expanded on feeder layer in the presence of added cytokines and PCM on average a 2.96-fold increase of CD34(+)CD71(-) and a 3.13-fold increase of CD34(+)HLA-DR(-) was observed. The total number of colony forming cells (35 +/- 2.65) indicated also that the yield of clonogenic progenitors obtained with a combination of all factors was two folds higher than each of these factors alone and ten time above control (3.67 +/- 2.52). In conclusion, the results of our study clearly show that the ex vivo expansion of hematopoietic progenitor cells obtained from human umbilical cord blood is dependent on controlled experimental conditions, which might be helpful when designing culture systems for clinical applications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15256070      PMCID: PMC6740219          DOI: 10.1111/j.1582-4934.2004.tb00277.x

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  31 in total

1.  Role of serum-free medium in the ex vivo expansion of human cord blood hematopoietic stem cells.

Authors:  R K Shadduck; G L Gilmore; J Lister
Journal:  Stem Cells       Date:  2000       Impact factor: 6.277

Review 2.  Translating stem and progenitor cell biology to the clinic: barriers and opportunities.

Authors:  I L Weissman
Journal:  Science       Date:  2000-02-25       Impact factor: 47.728

3.  A secreted and LIF-mediated stromal cell-derived activity that promotes ex vivo expansion of human hematopoietic stem cells.

Authors:  C C Shih; M C Hu; J Hu; Y Weng; P J Yazaki; J Medeiros; S J Forman
Journal:  Blood       Date:  2000-03-15       Impact factor: 22.113

4.  Murine stromal cells counteract the loss of long-term culture-initiating cell potential induced by cytokines in CD34(+)CD38(low/neg) human bone marrow cells.

Authors:  A Bennaceur-Griscelli; C Tourino; B Izac; W Vainchenker; L Coulombel
Journal:  Blood       Date:  1999-07-15       Impact factor: 22.113

5.  Ex-vivo expansion of bone marrow progenitor cells for hematopoietic reconstitution following high-dose chemotherapy for breast cancer.

Authors:  C R Bachier; E Gokmen; J Teale; S Lanzkron; C Childs; W Franklin; E Shpall; J Douville; S Weber; T Muller; D Armstrong; C F LeMaistre
Journal:  Exp Hematol       Date:  1999-04       Impact factor: 3.084

6.  Defining optimum conditions for the ex vivo expansion of human umbilical cord blood cells. Influences of progenitor enrichment, interference with feeder layers, early-acting cytokines and agitation of culture vessels.

Authors:  T Köhler; R Plettig; W Wetzstein; B Schaffer; R Ordemann; H O Nagels; G Ehninger; M Bornhäuser
Journal:  Stem Cells       Date:  1999       Impact factor: 6.277

7.  Serum-free ex vivo expansion of CD34(+) hematopoietic progenitor cells.

Authors:  D Möbest; R Mertelsmann; R Henschler
Journal:  Biotechnol Bioeng       Date:  1998-11-05       Impact factor: 4.530

8.  Rapid ex vivo expansion of human umbilical cord hematopoietic progenitors using a novel culture system.

Authors:  H Kawada; K Ando; T Tsuji; Y Shimakura; Y Nakamura; J Chargui; M Hagihara; H Itagaki; T Shimizu; S Inokuchi; S Kato; T Hotta
Journal:  Exp Hematol       Date:  1999-05       Impact factor: 3.084

9.  Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling.

Authors:  B Varnum-Finney; L Xu; C Brashem-Stein; C Nourigat; D Flowers; S Bakkour; W S Pear; I D Bernstein
Journal:  Nat Med       Date:  2000-11       Impact factor: 53.440

10.  Thrombopoietin, flt3, and kit ligands together suppress apoptosis of human mobilized CD34+ cells and recruit primitive CD34+ Thy-1+ cells into rapid division.

Authors:  L J Murray; J C Young; L J Osborne; K M Luens; R Scollay; B L Hill
Journal:  Exp Hematol       Date:  1999-06       Impact factor: 3.084

View more
  5 in total

1.  Trophic factor induction of human umbilical cord blood cells in vitro and in vivo.

Authors:  Ning Chen; Siddharth Kamath; Jennifer Newcomb; Jennifer Hudson; Svitlana Garbuzova-Davis; Paula Bickford; Cyndy Davis-Sanberg; Paul Sanberg; Tanja Zigova; Alison Willing
Journal:  J Neural Eng       Date:  2007-04-04       Impact factor: 5.379

2.  Expansion of human hematopoietic stem cells for transplantation: trends and perspectives.

Authors:  Hera Andrade-Zaldívar; Leticia Santos; Antonio De León Rodríguez
Journal:  Cytotechnology       Date:  2008-03-29       Impact factor: 2.058

3.  Expansion of engrafting human hematopoietic stem/progenitor cells in three-dimensional scaffolds with surface-immobilized fibronectin.

Authors:  Qi Feng; Chou Chai; Xue-Song Jiang; Kam W Leong; Hai-Quan Mao
Journal:  J Biomed Mater Res A       Date:  2006-09-15       Impact factor: 4.396

4.  In-vitro Behavior of Human Umbilical Cord Blood Stem Cells Towards Serum Based Minimal Cytokine Growth Conditions.

Authors:  Santwana Mantri; Praksh Chandra Mohapatra
Journal:  Indian J Clin Biochem       Date:  2013-05-29

5.  In vitro expansion of fetal liver hematopoietic stem cells.

Authors:  Rashmi Bhardwaj; Lalit Kumar; Deepika Chhabra; N K Mehra; Atul Sharma; Sujata Mohanty; Vinod Kochupillai
Journal:  Sci Rep       Date:  2021-06-04       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.